Capricor Therapeutics Announces Positive Topline Results from Pivotal Phase 3 HOPE-3 Study of Deramiocel in Duchenne Muscular Dystrophy
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 02/17/10 | Statement of changes in beneficial ownership of securities |
|
2 | ||
| 02/12/10 | Annual statement of changes in beneficial ownership of securities |
|
1 | ||
| 01/21/10 | Statement of changes in beneficial ownership of securities |
|
1 | ||
| 01/21/10 | Statement of changes in beneficial ownership of securities |
|
2 | ||
| 11/13/09 | SEC-generated letter |
|
1 | ||
| 11/12/09 | Quarterly report pursuant to Section 13 or 15(d) |
|
33 | ||
| 11/02/09 | Definitive proxy statements |
|
31 | ||
| 10/29/09 | Initial statement of beneficial ownership of securities |
|
2 | ||
| 10/01/09 | A correspondence can be sent as a document with another submission type or can be sent as a separate submission. |
|
6 | ||
| 09/29/09 | Current report filing |
|
8 |